Wikidata

(Q53017839)

English

A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial.

scientific article published on 17 August 2014

In more languages

Statements

title
A multicenter, open-label phase II study of metformin with erlotinib in second-line therapy of stage IV non-small-cell lung cancer patients: treatment rationale and protocol dynamics of the METAL trial. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
25242667
retrieved
10 May 2018
reference URL
http://europepmc.org/abstract/MED/25242667

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53017839&oldid=1744550608"